Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HYPOTESIS: Acipimox Effects on Cardiac Steatosis in T2D
NCT01980524Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Oct 2013
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acipimox in type 2 diabetes mellitus (T2DM), sponsored by Medical University of Vienna. Started Oct 2013; status: completed.
02
Drugs
acipimox
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01980524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01980524.